Wall Street brokerages expect Meridian Bioscience Inc. (NASDAQ:VIVO) to report sales of $49.74 million for the current quarter, according to Zacks. Two analysts have issued estimates for Meridian Bioscience’s earnings, with the highest sales estimate coming in at $50.03 million and the lowest estimate coming in at $49.44 million. Meridian Bioscience reported sales of $46.81 […]
